PETs are already being used in highly sensitive areas such as fraud investigation and rare disease medical research but their possible application can be envisaged in various other fields.
This session will bring together regulators, industry adopters and PET providers to determine sector-specific use cases through matchmaking and discussion.
- Healthcare
o State of affairs, Status and Challenges
o Implications & Opportunities
o Potential solutions & Value
• Asad Preuss-Dodhy, Data Privacy Technologies and Solutions Lead, Roche Diagnostics GmbHDay
- Financial Institutions
o Challenges & Reality
o Implications & Opportunities
o Potential solutions & Enterprise Value
- Government & Regulatory
o Statistics drivers
o Policies
• Lawrence Wee, Deputy Director, Ministry of Health Singapore
Asad Preuss-Dodhy
